Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

KIORA PHARMACEUTICALS INC (KPRX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $4.32 Metrics
OS: 7.25 M -89 % ROE
Market cap: $31.3 M
Net cash: $7.95 M $1.10 per share
EV: $23.4 M

 
TTM Valuation
EBITDA ($10.2) M
EBIT ($10.2) M
EPS ($11.24)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues0.014.70.02.71.70.40.70.0
            Revenue growth-100.0%121897.9%-99.6%62.5%305.5%-39.1%  
Cost of goods sold0.00.0-8.20.00.00.00.00.0
Gross profit0.014.78.22.71.70.40.70.0
            Gross margin 100.0%68304.8%100.0%100.0%100.0%100.0% 
Research and development3.45.43.65.48.110.38.42.7
General and administrative8.35.34.74.44.44.65.64.0
EBITA-11.7-10.6-8.2-7.2-11.0-14.6-13.4-6.2
            EBITA margin -72.4%-67897.5%-267.8%-663.1%-3572.5%-1994.8% 
Amortization of intangibles0.00.00.00.00.0   
EBIT-11.7-10.7-8.2-7.2-11.0-14.6-13.4-6.2
            EBIT margin -72.6%-68104.8%-268.7%-663.5%-3572.5%-1994.8% 
Pre-tax income-13.7-14.0-6.8-7.0-10.7-14.6-13.3-8.4
Income taxes-0.1-0.20.00.10.1-1.30.00.0
            Tax rate0.8%1.4%   9.2%0.0%0.0%
Net income-13.6-13.8-6.9-7.1-10.8-13.2-13.3-16.6
            Net margin -93.6%-56901.7%-264.2%-654.2%-3243.5%-1993.8% 
 
Diluted EPS($18.55)($57.12)($1.49)($2.23)($4.57)($0.93)($1.51)($2.70)
Shares outstanding (diluted)0.70.24.63.22.414.38.86.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy